<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Flomax Side Effects</title>
	<atom:link href="http://flomaxsideeffects.org/feed/" rel="self" type="application/rss+xml" />
	<link>http://flomaxsideeffects.org</link>
	<description></description>
	<lastBuildDate>Thu, 16 Feb 2012 23:26:36 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>What is Flomax?</title>
		<link>http://flomaxsideeffects.org/2010/12/02/what-is-flomax/</link>
		<comments>http://flomaxsideeffects.org/2010/12/02/what-is-flomax/#comments</comments>
		<pubDate>Thu, 02 Dec 2010 10:40:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://flomaxsideeffects.org/?p=71</guid>
		<description><![CDATA[Tamsulosin (rINN) (pronounced /tæmˈsuːlɵsɨn/ or tæmsʉˈloʊsɨn) is an α1a-selective alpha blocker used in the symptomatic treatment of benign prostatic hyperplasia (BPH). Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and is marketed by various companies under licence, &#8230; <a href="http://flomaxsideeffects.org/2010/12/02/what-is-flomax/">Read more...</a>]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;">Tamsulosin (rINN) (pronounced /tæmˈsuːlɵsɨn/ or tæmsʉˈloʊsɨn) is an α1a-selective alpha blocker used in the symptomatic treatment of benign prostatic hyperplasia (BPH). Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and is marketed by various companies under licence, including Boehringer-Ingelheim and CSL. Tamsulosin hydrochloride extended-release capsules are marketed under the trade names Flomax, Flomaxtra and Urimax, though generic non-modified release capsules are still approved and marketed in many countries, such as Canada. The U.S. patent for Flomax expired in October 2009. The U.S. Food and Drug Administration (FDA) approved generic Flomax in March 2010.<br />
In Egypt and Iceland it is marketed under the trade Omnic by Astellas Pharma Europe.</p>
]]></content:encoded>
			<wfw:commentRss>http://flomaxsideeffects.org/2010/12/02/what-is-flomax/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

